LTFS
CNST

Ladenburg Thalmann Financial Services’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Buy
+125
New +$3.61K ﹤0.01% 4737

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CNST Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Constellation Pharmaceuticals, Inc. (CNST) in Q4 2019: 125 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #4737 among its holdings.

100 funds tracked by Wall St. Rank hold CNST as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 125 shares of Constellation Pharmaceuticals, Inc. worth $6K as of Q4 2019.
  • Constellation Pharmaceuticals, Inc. was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • Constellation Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4737 holding.
  • 100 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.